Patient and physician perspectives on the care and assistance needs in Huntington’s disease
Objective: To describe the assistance needs of people with Huntington’s disease (HD) across different countries. Background: HD is a genetic, neurodegenerative and ultimately fatal disease…An adult type Niemann-Pick disease type C family: Huntington’s disease-like expression
Objective: We present a family with Niemann-Pick disease type C (NPC) expressing Huntington's disease-like involuntary movements. The process for the diagnosis may be a good…The Huntington’s Disease-Behavioral Questionnaire (HD-BQ): A New Screening Tool for Behavioral Disturbances in HD
Objective: To examine the usefulness of a new behavioral questionnaire for patients with, and at risk for, Huntington’s disease (HD). Background: Behavioral changes, including apathy,…Huntington’s Disease Protein Huntingtin Associates with its own mRNA
Objective: To investigate how Htt might affect RNA metabolism we set out to purify and analyze RNA associated with Htt. Background: The Huntington's disease (HD)…Clinical and imaging characteristics of manifest LRRK2 and GBA carriers: The PPMI cohort
Objective: To compare baseline clinical and imaging characteristics of the GBA and LRRK2 PD manifest cohorts to PD sporadic (sPD) cohort. Background: The phenotype and…Correlation between structural neuroimaging and clinical outcomes in a small sample of patients with early Huntington’s disease
Objective: Scores on the symbol digit modalities test (SDMT), Stroop word-reading, Total Motor Score (TMS) and composite UHDRS (cUHDRS) are correlated with disease progression and…Mobility Impairments in Huntington’s Disease due to Cognitive Dysfunction
Objective: This study examined the relationships of mobility, motor and cognitive function measures at baseline, and of mobility and cognitive measures over four years Background:…Clinical and imaging characteristics of non-manifest LRRK2 and GBA carriers: The PPMI cohort
Objective: To examine baseline clinical and dopamine transporter (DAT) imaging characteristics in a cohort of non-manifest carriers (NMC) of GBA and LRRK2 compared to healthy…Cerebellar Ataxia in Patients with Huntington’s Disease, an underestimated symptom?
Objective: To analyze the prevalence of cerebellar ataxia in patients with Huntington’s Disease (HD), both early and late on HD progression and correlating the degree…Factors underlying reduced aerobic capacity in Huntington disease
Objective: Examine factors underlying aerobic capacity in prodromal and manifest Huntington disease (HD) and matched controls Background: HD results in motor impairments, weight loss, muscle…
- « Previous Page
- 1
- …
- 16
- 17
- 18
- 19
- 20
- …
- 23
- Next Page »